Atherectomy Devices Market Expected To Grow At 7% CAGR From 2014 To 2025

The worldwide atherectomy devices market is anticipated to reach nearly USD 895 million by 2025. It was valued at USD 488.04 million in 2016. And is predicted to grow at a CAGR of approximately 7% over the forecast period (2014 to 2025). The market is expected to expand due to the rising prevalence of peripheral artery disease (PAD). Increasing demand for minimally invasive surgery (MIS) is expected to drive the global market in the forthcoming years.

Atherectomy is a medical procedure conducted by interventional cardiologists. It is performed to remove atherosclerotic plaque restricting blood flow within the arteries. The devices used in treating these are called atherectomy devices. These are mostly used in the treatment of PAD, atherosclerosis, and critical limb ischemia (CLI). One of the major drawbacks of this procedure is the huge deposits of calcified plaque. If left untreated, it could lead to chronic kidney disease or type 2 diabetes. The heavily calcified lesions require advanced devices which can prevent the chances of barotrauma. Recently, Medtronic developed TurboHawk and SilverHawk plaque excision systems. These are devices that are embedded with a collection area to accumulate excess plaque. 

These devices obtained approval from the US Food & Drug Administration in 2014 in the area of atherectomy of peripheral vasculature. The DEFINITIVE LE (determination of effectiveness of the SilverHawk peripheral plaque excision system for infrainguinal vessels/lower extremities treatment) trial recorded 78 percent success rate in claudicant patients and 95 percent success rate in patients with CLI respectively. The global market is characterized by product developments. In 2016, Avinger Inc., a US-based company, received its 501 (K) clearance for the advanced version of Pantheris lumivascular atherectomy system. Some of its advanced features include an intravascular image-guided system which allows interventionists to guide the catheter during atherectomy. Its safety and efficiency was proven successful during the VISION trial. 

In-depth research report on global atherectomy devices market - http://www.grandviewresearch.com/industry-analysis/atherectomy-device-market

The global atherectomy devices market is fragmented according to types and regions. On the basis of types, the market is split into laser, directional, rotational, and orbital atherectomy devices. Directional devices led the global market in terms of revenue in 2016. The ability of these devices to collect shaved plaque can reduce the risks of neointimal hyperplasia and barotrauma. Successful clinical studies like EASE (Endovascular Atherectomy Safety and Effectiveness) which have proven the efficiency of these devices can contribute to the device’s high demand in the years to come. Laser atherectomy devices are anticipated to display a high growth rate during the forecast period. These devices are believed to be highly accurate in plaque removal. However, they may cause a few complications. Rotational atherectomy devices are expected to grow remarkably on account of the procedure having a nearly 96% success rate. 

Key geographical segments are Latin America, North America, Europe, Middle East & Africa (MEA), and Asia Pacific (APAC). North America dominated the global market in 2015 on account of large market shares. It is expected to continue dominating the overall market over the forecast period due to high the high prevalence of PAD in the region. APAC is anticipated to expand robustly in the forthcoming years. Factors such as lifestyle changes, aging populace, and socioeconomic changes can contribute to regional growth.

Prominent players in the atherectomy devices market are Straub Medical AG, Spectranetics, Medtronic (Covidien), Terumo IS (Interventional Systems), and Boston Scientific Corporation. Most of these companies engage in distribution agreements and expansion strategies. For instance, Cardiovascular Systems, Inc. signed an agreement with Medikit Co., Ltd. to distribute its products in 2016. This has given the former access to more than 800 hospitals in Japan.

Source: Atherectomy Devices Market Analysis & Segment Forecast Report, 2025

Request free sample